Weronika Maria Szejniuk

BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study

Amber Louw, Vasiliki Panou, Weronika Maria Szejniuk et al. · Journal of Thoracic Oncology · 2022 · 62 citations · Full text

Medicine, Oncology, Pathology +17

Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics

Shona Pedersen, Katrine Papendick Jensen, Bent Honoré et al. · Clinical Proteomics · 2022 · 36 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – A phase II randomised trial

Vilde Drageset Haakensen, Åsa Kristina Öjlert, Solfrid Thunold et al. · European Journal of Cancer · 2024 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Identifying metabolic alterations in newly diagnosed small cell lung cancer patients

Shona Pedersen, Joachim Bavnhøj Hansen, Raluca Maltesen et al. · Metabolism Open · 2021 · 18 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma

Louise Andersen Lynggård, Vasiliki Panou, Weronika Maria Szejniuk et al. · Journal of the American Society of Cytopathology · 2022 · 15 citations · Full text

Medicine, Oncology, Pathology +17